Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 May 03

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 May 03

DOI: 10.23736/S1824-4785.17.02966-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Comprehensive metabolic and morphologic disease characterization in systemic sclerosis: initial results using combined positron emission tomography and magnetic resonance imaging

Alexander W. SAUTER 1, 2, Sergios GATIDIS 1, Nina F. SCHWENZER 3, Christian LA FOUGÈRE 3, Konstantin NIKOLAOU 1, Joerg C. HENES 4, Marius HORGER 1

1 Eberhard Karls University, Department of Radiology, Diagnostic and Interventional Radiology, Tuebingen, Germany; 2 University Hospital Basel, Clinic of Radiology and Nuclear Medicine, Basel, Switzerland; 3 Eberhard Karls University, Department of Radiology, Nuclear Medicine, Tuebingen, Germany; 4 Eberhard Karls University, Department of Internal Medicine II, Oncology, Hematology, Immunology, Rheumatology, Pulmology, Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases, Tuebingen, Germany


PDF  


BACKGROUND: To evaluate the role of metabolic and morphologic parameters derived from simultaneous hybrid PET/MRI in correlation to clinical criteria for an image-based characterization of musculoskeletal, esophagus and lymph node involvement in systemic sclerosis (SSc).
METHODS: Between November 2013 and May 2015, simultaneous whole-body hybrid PET/MRI was performed in 13 prospectively recruited patients with SSc. A mean dose of 241.3 MBq 2-deoxy-2- [18F]fluoro-D-glucose (FDG) was injected. SUVmean and SUVmax values were measured in the spinal bone marrow, spleen, joints, muscles, fasciae, mediastinal lymph nodes and esophagus. MRI abnormalities were scored as 0 (absent), 1 (moderate) and 2 (marked). In addition, organ and skin involvement were graded with clinical sum score (CSS) and modified Rodnan skin score (mRSS), respectively.
RESULTS: Results indicate positive correlations between mRSS and fascial FDG-uptake values (fascia summed SUVmax p= 0.67; fascia summed SUVmean p = 0.66) that performed better than the MRI sum score (p = 0.50). Fascial FDG-uptake is also useful in the differentiation between diffuse and limited SSc. Additionally, FDG-PET detected patients with active mediastinal lymphadenopathy and MRI proved to be useful for the delineation of esophagus involvement.
CONCLUSIONS: Fascial FDG-uptake has a strong correlation with mRSS and can discriminate between limited and diffuse SSc. These results and the detection of active lymphadenopathy and esophagus involvement can identify patients with advanced scleroderma. Combined PET/MRI therefore provides complementary information on the complex pathophysiology and may integrate several imaging procedures in one.


KEY WORDS: Systemic sclerosis - Positron emission tomography - Magnetic resonance imaging - Multimodal imaging

top of page

Publication History

Cite this article as

Sauter AW, Gatidis S, Schwenzer NF, La Fougère C, Nikolaou K, Henes JC, et al. Comprehensive metabolic and morphologic disease characterization in systemic sclerosis: initial results using combined positron emission tomography and magnetic resonance imaging. Q J Nucl Med Mol Imaging 2017 May 03. DOI: 10.23736/S1824-4785.17.02966-1

Corresponding author e-mail

alexander.sauter.imaging@gmail.com